Trial Profile
Comparison of the pharmacodynamics and pharmacokinetics of insulin aspart and human soluble insulin in geriatric subjects with type 2 diabetes mellitus.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs Insulin aspart (Primary) ; Insulin
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Sponsors Novo Nordisk
- 06 May 2009 Actual patient number (19) added as reported by ClinicalTrials.gov.
- 06 May 2009 Actual end date (Jul 2002) added as reported by ClinicalTrials.gov.
- 03 Jun 2008 New trial record.